000 marine micro-organisms.

Aquapharm discovers new antibiotic compound against multi-drug resistant bacteria A substantial discovery in the development of next-generation antibiotics has been created by Scottish biotechnology company Aquapharm. The compound, ‘AQP-182’, is among a true number of druggable brand-new molecules determined by Aquapharm from its collection of a lot more than 10,000 marine micro-organisms digestion processes . Its researchers screened a fraction of the collection to look recently for micro-organisms which may have anti-inflammatory and anti-infective properties – and discovered 16 compounds with powerful pharmacological potential.